Läs: http://childhealthsafety.wordpress.com/2011/04/20/hpv-experiments-for-drug-industry/
SANEVax News Release
Parents of Daughters & Women Injured from Gardasil
React to FDA Decision
React to FDA Decision
Why are medical consumers the medical experiments?
Safety and efficacy studies should be conducted for all intended age intended before market release.
Safety and efficacy studies should be conducted for all intended age intended before market release.
On April 7, 2011 the media broke the news about the U.S. FDA’s ruling against Merck’s supplemental biologics license application (sBLA) for an indication to use GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in women ages 27-45. This was Merck’s 4th request to expand Gardasil use to an older population of women.
According to a report in MedPage Today,‘The decision was based on a trial in 3,253 women ages 27 to 45. Although the vaccine appeared to prevent persistent HPV infection, no significant benefit was found for more important outcomes such as high-grade neoplastic lesions or cervical cancer when all participants were included irrespective of baseline HPV status.’
Within days the news of the FDA’s decision traveled across the country and across the world. SANE Vax Inc. asked parents whose daughters have been injured by the vaccine as well as victims themselves to comment on the decision.
Inga kommentarer:
Skicka en kommentar